Steroid Avoidance, Dexamethasone, and RAGE Inhibition for Perioperative Cerebral Edema Management in High-Grade Gliomas
Steroid Avoidance, Dexamethasone, and RAGE Inhibition for Perioperative Cerebral Edema Management in High-Grade Gliomas
Not yet recruiting · NCT07694089 · Registry updated 2026-07-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Steroid Avoidance, Dexamethasone, and RAGE Inhibition for Perioperative Cerebral Edema Management in High-Grade Gliomas | High-grade Gliomas (HGG) | Not yet recruiting | Phase 2 | 2026-07-09 | NCT07694089 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Akshitkumar MIstry | 1 |
| Cantex Pharmaceuticals Inc. | 1 |
| James Graham Brown Cancer Center | 6 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UofL Health Brown Cancer Center; University of Louisville Hospital | Louisville | United States | 1 |
| UofL Health Jewish Hospital | Louisville | United States | 1 |